Cite
HARVARD Citation
Barni, S. et al. (2019). Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study. Journal of geriatric oncology. 10 (6), pp. 990-993. [Online].